EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $235,982 | -64.2% | 8,318 | -63.1% | 0.04% | -72.2% |
| Q4 2022 | $659,049 | -47.7% | 22,547 | -52.8% | 0.16% | -44.9% |
| Q3 2022 | $1,261,000 | +481.1% | 47,727 | +876.6% | 0.29% | +394.8% |
| Q2 2022 | $217,000 | -43.8% | 4,887 | -37.3% | 0.06% | -44.2% |
| Q1 2022 | $386,000 | +15.6% | 7,800 | +4.2% | 0.10% | -68.4% |
| Q4 2018 | $334,000 | -3.7% | 7,488 | +49.8% | 0.33% | +39.4% |
| Q3 2018 | $347,000 | +54.2% | 5,000 | +18.5% | 0.24% | +42.2% |
| Q4 2017 | $225,000 | – | 4,218 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |